Friday, June 19, 2026
🇺🇸 FDA

pharma · Metastatic Colorectal Cancer · Duchenne Muscular Dystrophy · SMMT

Summit Therapeutics

Summit Therapeutics patent portfolio — 20 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US HQ
2003 Founded
367 Employees
Public company Type
SMMT · NYSE Ticker
Company details
Status
Public
HQ
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US
Founded
2003
Employees
367
Programs
41
Drugs
32
Patents
20
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Summit Therapeutics patents

20 pharmaceutical patents indexed for Summit Therapeutics. 1 expire within 24 months.

Summit Therapeutics has 20 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

20 patents

Patent portfolio

  1. US 12318487

    Solid tablet dosage form of ridinilazole

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11344575

    Vascular calcification prevention and treatment

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11007171

    Treatment and prevention of joint disorders

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9763925

    Antibacterial compounds

    Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9492433

    Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9314456

    Antibacterial compounds

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9278091

    Compounds for the treatment of Clostridium difficile associated disease

    Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8987308

    Compounds for the treatment of Clostridium difficile-associated disease

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8975416

    Antibacterial compounds

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8557859

    Immunomodulatory compositions

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8518980

    Treatment of Duchenne muscular dystrophy

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8383665

    Immunomodulatory compositions

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8183204

    Methods and compositions for increasing skin remodeling

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8138351

    Treatment of duchenne muscular dystrophy

    Expires Mon Mar 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8124059

    Stabilized aqueous aluminum zirconium solutions

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7906535

    High concentration topical insecticides containing pyrethroids

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7731943

    Stabilized aqueous aluminum zirconium solutions

    Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7368435

    Topical endoparasiticide and ectoparasiticide formulations

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 6269157

    Bidding for telecommunications traffic with request for service

    Expires Mon Jul 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Summit Therapeutics have?

20 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Summit Therapeutics patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.